World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE – Times of Oman

World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE – Times of Oman

World's first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE

Image used for illustrative purpose

Abu Dhabi: The first WHO-enlisted global phase III clinical trial of Sinopharm CNBG's inactivated vaccine to combat COVID-19 has started in Abu Dhabi in the United Arab Emirates (UAE), and has been inspired by the UAE leadership's vision and commitment to overcome the pandemic through a global collaborative effort.

HE Sheikh Abdullah bin Mohammed Al Hamed, Chairman of the Department of Health, Abu Dhabi, was the first individual in the world to commence the trial of a phase III inactivated vaccine for COVID-19. The department's Acting Undersecretary, Dr Jamal Al Kaabi was the second volunteer to trial the vaccine showcasing the commitment of the UAE government and the Health Authorities to find a cure for humanity's biggest challenge of the 21st century.

The world's first phase III trial is the result of a partnership between Abu Dhabi based G42 Healthcare, currently at the forefront of the battle against COVID-19 in the UAE, and Sinopharm CNBG, the world's sixth largest vaccine manufacturer, ranked 169th on the Fortune Global 500 list of 2018.

The trials are being operated by health practitioners from Abu Dhabi Health Services (SEHA) who are